BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19106650)

  • 41. XVI. CNS prophylaxis in aggressive lymphomas: for whom and how.
    Benevolo G; Chiappella A; Vitolo U
    Hematol Oncol; 2013 Jun; 31 Suppl 1():89-91. PubMed ID: 23775658
    [No Abstract]   [Full Text] [Related]  

  • 42. Advantages of flow cytometry immunophenotyping for the diagnosis of central nervous system non-Hodgkin's lymphoma in AIDS patients.
    Subirá D; Górgolas M; Castañón S; Serrano C; Román A; Rivas F; Tomás JF
    HIV Med; 2005 Jan; 6(1):21-6. PubMed ID: 15670248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.
    Recht L; Straus DJ; Cirrincione C; Thaler HT; Posner JB
    Am J Med; 1988 Mar; 84(3 Pt 1):425-35. PubMed ID: 3348245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
    Chamberlain MC; Glantz M; Groves MD; Wilson WH
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S35-45. PubMed ID: 19660682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CNS prophylaxis and treatment in non-Hodgkin's lymphoma: variation in practice and lessons from the literature.
    Buckstein R; Lim W; Franssen E; Imrie KL
    Leuk Lymphoma; 2003 Jun; 44(6):955-62. PubMed ID: 12854893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma.
    Lazar AD; Shpilberg O; Shaklai M; Bairey O
    Isr Med Assoc J; 2009 Jan; 11(1):16-22. PubMed ID: 19344007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies.
    Galati D; Di Noto R; Del Vecchio L
    Leuk Res; 2013 Mar; 37(3):231-7. PubMed ID: 23287431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma: Who, What, and When?
    Schmitz N; Nickelsen M; Savage KJ
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1277-1291. PubMed ID: 27888881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary central nervous system lymphoma.
    Tomita N; Kodama F; Kanamori H; Motomura S; Ishigatsubo Y
    Int J Hematol; 2006 Aug; 84(2):128-35. PubMed ID: 16926134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leukemia and lymphoma: what is the role for intrathecal prophylactic treatment in adults?
    Garcia-Manero G; Glantz M
    Expert Rev Neurother; 2004 Jul; 4(4 Suppl):S25-31. PubMed ID: 15853552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A form of "creeping" involvement of the central nervous system in lymphoblastic leukemia and non-Hodgkin's malignant lymphoma in children].
    Kubiczek K; Rytlewska M; Dłuzniewska A; Grotyński M; Kałuza J
    Pol Tyg Lek; 1987 Aug; 42(33):1012-5. PubMed ID: 3480509
    [No Abstract]   [Full Text] [Related]  

  • 52. Primary central nervous system lymphoma.
    Mohile NA; Abrey LE
    Neurol Clin; 2007 Nov; 25(4):1193-207, xi. PubMed ID: 17964031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of unfit patients with unfavourable non-Hodgkin's lymphomas.
    Soubeyran P; Mertens C; Bellera C; Mathoulin-Pélissier S; Rainfray M
    Cancer Treat Rev; 2009 Oct; 35(6):528-32. PubMed ID: 19762154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary central nervous system lymphoma.
    Ferreri AJ; Reni M
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secondary breast, pancreatic, and renal involvement with non-Hodgkin's lymphoma: Imaging findings.
    Kiresi DA; Kivrak AS; Ecirli S; Toy H
    Breast; 2006 Feb; 15(1):106-10. PubMed ID: 16473741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphomatous meningitis: early diagnosis and treatment.
    Van Horn A
    Clin J Oncol Nurs; 2009 Feb; 13(1):90-4. PubMed ID: 19193553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience.
    Zinzani PL; Magagnoli M; Frezza G; Prologo G; Gherlinzoni F; Bendandi M; Albertini P; Babini L; D'Alessandro R; Tura S
    Leuk Lymphoma; 1999 Feb; 32(5-6):571-6. PubMed ID: 10048430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary CNS lymphoma.
    Hochberg FH; Baehring JM; Hochberg EP
    Nat Clin Pract Neurol; 2007 Jan; 3(1):24-35. PubMed ID: 17205072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testicular lymphoma is associated with a high risk of extranodal recurrence.
    Lote K; Holte H; Kvaloy S
    Cancer; 2000 Aug; 89(3):713-4. PubMed ID: 10931479
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk of CNS dissemination in extranodal lymphomas.
    Ferreri AJ
    Lancet Oncol; 2014 Apr; 15(4):e159-69. PubMed ID: 24694639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.